Evidence map›Paper›PMID 40047271›Full record

ArticleAmerican journal of physiology. Renal physiology2025

Fueling kidney recovery: boosting BCAA metabolism to overcome nephrotoxic AKI.

Pinelopi P Kapitsinou

Abstract readEditorial
In one paragraph

Article in American journal of physiology. Renal physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Pinelopi P KapitsinouFeinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States.ORCID 0000-0002-6953-0988

Funding

Resource Development CoreU54DK137516 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Eun Ji Paige Chung, Pinelopi P. Kapitsinou · 2023 to 2026
$4.8M
Endothelial PHD2/HIF Axis in Ischemic Kidney Injury and InflammationR01DK115850 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Pinelopi P. Kapitsinou · 2018 to 2026
$3.5M
Harnessing hypoxia responses to treat postischemic kidney injury and inflammationR01DK132672 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KAPITSINOU, PINELOPI P. · 2022 to 2024
$710k
Compartment-specific manipulation of NAD+ to mitigate post-injury kidney disease.R21AG086806 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KAPITSINOU, PINELOPI P. · 2024 to 2024
$438k
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK115850HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK132672NIA NIH HHS R21 AG086806NIDDK NIH HHS R01 DK115850NIDDK NIH HHS R01 DK132672NIDDK NIH HHS U54 DK137516
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40047271
PMCPMC12087460

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.